BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20571122)

  • 1. Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis.
    Zhu Q; Hegde PU; Ricci A; Kane M; Cronin EB; Ardeshirpour Y; Xu C; Aguirre A; Kurtzman SH; Deckers PJ; Tannenbaum SH
    Radiology; 2010 Aug; 256(2):367-78. PubMed ID: 20571122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Functional Differences in Malignant and Benign Breast Lesions and Improvement of Diagnostic Accuracy by Using US-guided Diffuse Optical Tomography in Conjunction with Conventional US.
    Zhu Q; Ricci A; Hegde P; Kane M; Cronin E; Merkulov A; Xu Y; Tavakoli B; Tannenbaum S
    Radiology; 2016 Aug; 280(2):387-97. PubMed ID: 26937708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction.
    Zhu Q; Cronin EB; Currier AA; Vine HS; Huang M; Chen N; Xu C
    Radiology; 2005 Oct; 237(1):57-66. PubMed ID: 16183924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US-guided optical tomography: correlation with clinicopathologic variables in breast cancer.
    Choi JS; Kim MJ; Youk JH; Moon HJ; Suh HJ; Kim EK
    Ultrasound Med Biol; 2013 Feb; 39(2):233-40. PubMed ID: 23219038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid breast lesions: clinical experience with US-guided diffuse optical tomography combined with conventional US.
    Zhi W; Gu X; Qin J; Yin P; Sheng X; Gao SP; Li Q
    Radiology; 2012 Nov; 265(2):371-8. PubMed ID: 23012460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US-guided diffused optical tomography: a promising functional imaging technique in breast lesions.
    You SS; Jiang YX; Zhu QL; Liu JB; Zhang J; Dai Q; Liu H; Sun Q
    Eur Radiol; 2010 Feb; 20(2):309-17. PubMed ID: 19707770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.
    Zhu Q; Kurtzma SH; Hegde P; Tannenbaum S; Kane M; Huang M; Chen NG; Jagjivan B; Zarfos K
    Neoplasia; 2005 Mar; 7(3):263-70. PubMed ID: 15799826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases.
    Zhu Q; Huang M; Chen N; Zarfos K; Jagjivan B; Kane M; Hedge P; Kurtzman SH
    Neoplasia; 2003; 5(5):379-88. PubMed ID: 14670175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.
    Zhu Q; Tannenbaum S; Kurtzman SH
    Surg Oncol Clin N Am; 2007 Apr; 16(2):307-21. PubMed ID: 17560514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting angiogenesis in breast tumors: comparison of color Doppler flow imaging with ultrasound-guided diffuse optical tomography.
    Zhu Q; You S; Jiang Y; Zhang J; Xiao M; Dai Q; Sun Q
    Ultrasound Med Biol; 2011 Jun; 37(6):862-9. PubMed ID: 21531497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of shear-wave elastography during second-look MR imaging-directed breast US: effect on lesion detection and biopsy targeting.
    Plecha DM; Pham RM; Klein N; Coffey A; Sattar A; Marshall H
    Radiology; 2014 Sep; 272(3):657-64. PubMed ID: 24758557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions.
    Moon JH; Kim HH; Shin HJ; Kim H; Ko MS; Gong G
    AJR Am J Roentgenol; 2011 Sep; 197(3):732-9. PubMed ID: 21862818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.
    Zhu Q; Tannenbaum S; Hegde P; Kane M; Xu C; Kurtzman SH
    Neoplasia; 2008 Oct; 10(10):1028-40. PubMed ID: 18813360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adding diffuse optical tomography to sonography improve differentiation between benign and malignant breast lesions? Observer performance study.
    La Yun B; Kim SM; Jang M; Ahn HS; Lyou CY; Kim MS; Kim SA; Song TK; Yoo Y; Chang JH; Kim Y
    J Ultrasound Med; 2015 May; 34(5):749-57. PubMed ID: 25911706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesions.
    Lv N; He N; Wu Y; Xie C; Wang Y; Kong Y; Wei W; Wu P
    Eur Radiol; 2014 Nov; 24(11):2848-56. PubMed ID: 25097131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.
    Poellinger A; Persigehl T; Mahler M; Bahner M; Ponder SL; Diekmann F; Bremer C; Moesta T
    Invest Radiol; 2011 Nov; 46(11):697-704. PubMed ID: 21788905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
    Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
    Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating benign from malignant solid breast masses with US strain imaging.
    Burnside ES; Hall TJ; Sommer AM; Hesley GK; Sisney GA; Svensson WE; Fine JP; Jiang J; Hangiandreou NJ
    Radiology; 2007 Nov; 245(2):401-10. PubMed ID: 17940302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
    Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
    Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.